Publication Information

{'id': 'https://openalex.org/W2400966550', 'doi': None, 'title': '[Prevention of toxoplasmosis in immunocompromised patients].', 'display_name': '[Prevention of toxoplasmosis in immunocompromised patients].', 'publication_year': 1997, 'publication_date': '1997-01-01', 'ids': {'openalex': 'https://openalex.org/W2400966550', 'mag': '2400966550', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/9255332'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/9255332', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5062233039', 'display_name': 'P. Morlat', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210111110', 'display_name': 'Hôpital Saint-André', 'ror': 'https://ror.org/021959v84', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3018323443', 'https://openalex.org/I4210111110']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'P Morlat', 'raw_affiliation_strings': ['Service de Médecine Interne, Hôpital Saint-André, Bordeaux.'], 'affiliations': [{'raw_affiliation_string': 'Service de Médecine Interne, Hôpital Saint-André, Bordeaux.', 'institution_ids': ['https://openalex.org/I4210111110']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5079654599', 'display_name': 'C Leport', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'C Leport', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.436778, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 66, 'max': 69}, 'biblio': {'volume': '148', 'issue': '3', 'first_page': '235', 'last_page': '9'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12369', 'display_name': 'Pneumocystis jirovecii pneumonia detection and treatment', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12369', 'display_name': 'Pneumocystis jirovecii pneumonia detection and treatment', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11155', 'display_name': 'Toxoplasma gondii Research Studies', 'score': 0.9922, 'subfield': {'id': 'https://openalex.org/subfields/2405', 'display_name': 'Parasitology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13374', 'display_name': 'Hematological disorders and diagnostics', 'score': 0.9864, 'subfield': {'id': 'https://openalex.org/subfields/2711', 'display_name': 'Emergency Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/atovaquone', 'display_name': 'Atovaquone', 'score': 0.88050735}, {'id': 'https://openalex.org/keywords/chemoprophylaxis', 'display_name': 'Chemoprophylaxis', 'score': 0.86343837}, {'id': 'https://openalex.org/keywords/toxoplasmosis', 'display_name': 'Toxoplasmosis', 'score': 0.8363147}, {'id': 'https://openalex.org/keywords/dapsone', 'display_name': 'Dapsone', 'score': 0.7616292}, {'id': 'https://openalex.org/keywords/opportunistic-infection', 'display_name': 'Opportunistic infection', 'score': 0.5408914}, {'id': 'https://openalex.org/keywords/immunosuppression', 'display_name': 'Immunosuppression', 'score': 0.4386565}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9363072}, {'id': 'https://openalex.org/C2779124865', 'wikidata': 'https://www.wikidata.org/wiki/Q418179', 'display_name': 'Atovaquone', 'level': 4, 'score': 0.88050735}, {'id': 'https://openalex.org/C2776688490', 'wikidata': 'https://www.wikidata.org/wiki/Q1069606', 'display_name': 'Chemoprophylaxis', 'level': 2, 'score': 0.86343837}, {'id': 'https://openalex.org/C2778269047', 'wikidata': 'https://www.wikidata.org/wiki/Q2555060', 'display_name': 'Sulfadiazine', 'level': 3, 'score': 0.8464309}, {'id': 'https://openalex.org/C2778062946', 'wikidata': 'https://www.wikidata.org/wiki/Q154878', 'display_name': 'Toxoplasmosis', 'level': 2, 'score': 0.8363147}, {'id': 'https://openalex.org/C2777035104', 'wikidata': 'https://www.wikidata.org/wiki/Q421072', 'display_name': 'Pyrimethamine', 'level': 4, 'score': 0.7776313}, {'id': 'https://openalex.org/C2777640609', 'wikidata': 'https://www.wikidata.org/wiki/Q422226', 'display_name': 'Dapsone', 'level': 2, 'score': 0.7616292}, {'id': 'https://openalex.org/C2777458120', 'wikidata': 'https://www.wikidata.org/wiki/Q422273', 'display_name': 'Clindamycin', 'level': 3, 'score': 0.62281966}, {'id': 'https://openalex.org/C2779196057', 'wikidata': 'https://www.wikidata.org/wiki/Q835718', 'display_name': 'Opportunistic infection', 'level': 4, 'score': 0.5408914}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.4540641}, {'id': 'https://openalex.org/C2780252810', 'wikidata': 'https://www.wikidata.org/wiki/Q1455316', 'display_name': 'Immunosuppression', 'level': 2, 'score': 0.4386565}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.33459625}, {'id': 'https://openalex.org/C2778048844', 'wikidata': 'https://www.wikidata.org/wiki/Q12156', 'display_name': 'Malaria', 'level': 2, 'score': 0.31897533}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2784156}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.21347773}, {'id': 'https://openalex.org/C2780727368', 'wikidata': 'https://www.wikidata.org/wiki/Q1928978', 'display_name': 'Viral disease', 'level': 3, 'score': 0.2111184}, {'id': 'https://openalex.org/C2777425658', 'wikidata': 'https://www.wikidata.org/wiki/Q422438', 'display_name': 'Chloroquine', 'level': 3, 'score': 0.1593731}, {'id': 'https://openalex.org/C2778371730', 'wikidata': 'https://www.wikidata.org/wiki/Q311383', 'display_name': 'Plasmodium falciparum', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C89423630', 'wikidata': 'https://www.wikidata.org/wiki/Q7193', 'display_name': 'Microbiology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D016867', 'descriptor_name': 'Immunocompromised Host', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D014123', 'descriptor_name': 'Toxoplasmosis', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': True}, {'descriptor_ui': 'D017088', 'descriptor_name': 'AIDS-Related Opportunistic Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017088', 'descriptor_name': 'AIDS-Related Opportunistic Infections', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016377', 'descriptor_name': 'Organ Transplantation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016377', 'descriptor_name': 'Organ Transplantation', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D012307', 'descriptor_name': 'Risk Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014123', 'descriptor_name': 'Toxoplasmosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/9255332', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.86, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W58336000', 'https://openalex.org/W2400966550', 'https://openalex.org/W2338892227', 'https://openalex.org/W2146861732', 'https://openalex.org/W2145573477', 'https://openalex.org/W2110024402', 'https://openalex.org/W2079207381', 'https://openalex.org/W1966811616', 'https://openalex.org/W1637453453', 'https://openalex.org/W134597131'], 'abstract_inverted_index': {'The': [0], 'main': [1], 'underlying': [2], 'immunosuppressive': [3], 'conditions': [4], 'requiring': [5], 'prevention': [6, 66], 'of': [7, 35, 67], 'toxoplasmosis': [8], 'are': [9, 104], 'organ': [10], 'transplantations': [11], '(especially': [12], 'heart': [13], 'and': [14, 18, 41, 44, 102], 'bone': [15], 'marrow': [16], 'transplants)': [17], 'advanced': [19], 'HIV': [20, 62], 'infection': [21], '(CD4': [22], '+': [23], 'lymphocytes': [24], 'count': [25], '<': [26], '100/mm3).': [27], 'Preventive': [28], 'strategies': [29], 'consist': [30], 'in': [31, 47, 58], 'reducing': [32], 'the': [33, 52, 54, 82], 'rate': [34], 'primary': [36, 78], 'infection,': [37], 'mainly': [38], 'through': [39], 'hygiene': [40], 'diet': [42], 'measures,': [43], 'introducing': [45], 'chemoprophylaxis': [46], 'patients': [48, 69, 86], 'already': [49], 'contaminated': [50], 'by': [51], 'parasite:': [53], 'most': [55], 'precise': [56], 'knowledge': [57], 'this': [59], 'field': [60], 'concerns': [61], 'infected': [63], 'patients.': [64], 'For': [65, 77], 'recurrence,': [68], 'should': [70], 'receive': [71], 'pyrimethamine-sulfadiazine,': [72], 'or': [73], 'otherwise': [74], 'pyrimethamine-clindamycin': [75], 'combinations.': [76], 'prophylaxis,': [79], 'cotrimoxazole': [80], 'is': [81, 96], 'first-line': [83], 'therapy.': [84], 'If': [85], 'cannot': [87], 'tolerate': [88], 'cotrimoxazole,': [89], 'a': [90, 97], 'regiment': [91], 'including': [92], 'dapsone': [93], 'plus': [94], 'pyrimethamine': [95, 100], 'possible': [98], 'alternative;': [99], 'alone': [101], 'atovaquone': [103], 'currently': [105], 'under': [106], 'investigation.': [107]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2400966550', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-12T07:19:48.539836', 'created_date': '2016-06-24'}